Please see full Prescribing Information, including Patient Information and Important Safety Information: bit.ly/3xgURXR Learn more about SAPHNELO® (anifrolumab-fnia), the first FDA-approved treatment for adults with moderate to severe SLE (or lupus) in over a decade. IMPORTANT PRODUCT INFORMATION For adults with moderate to severe SLE (lupus) on other lupus medicines. Not for severe active lupus nephritis or CNS lupus. Serious, sometimes fatal, infections have occurred. Seek medical attention right away if you have symptoms of allergic reactions (eg, swelling of face, mouth or tongue, breathing problems, dizziness). Serious allergic reactions can be delayed. Tell your doctor if you have/had cancer. Tell your doctor about side effects that may include upper respiratory infections, bronchitis, infusion reactions, shingles and cough. Do not use with other biologics or if allergic to SAPHNELO.

Be the first to comment